Mime-Version: |
1.0 |
Content-Type: |
text/plain; charset=US-ASCII |
Date: |
Mon, 31 Oct 2011 15:56:39 -0400 |
Content-Disposition: |
inline |
Reply-To: |
|
Subject: |
|
Content-Transfer-Encoding: |
quoted-printable |
Sender: |
|
From: |
|
Parts/Attachments: |
|
|
Co-trimoxazole is an antibiotic that reduces rates of opportunistic infections, such as malaria, diarrhea, and pneumonia, and death among adults and children living with HIV. Access to this intervention, however, remains inconsistent. A key barrier to appropriate Co-trimoxazole use is limited awareness about the benefits of using the antibiotic as a prophylaxis.Through a collaborative effort involving USAID, CDC, and clinicians and behavior change specialists in Uganda, AIDSTAR-One developed job aids, posters, and brochures for the household and health care levels to provide clear and accessible instructions for proper Co-trimoxazole use.
Access the materials on the AIDSTAR-One website: http://j.mp/uj2p9z
John Nicholson | Knowledge Management/Communications Manager
202.276.0624| Direct
703.528.7474 | Office
John Snow Inc.
To manage subscriptions/passwords, or view archives, go to http://listserv.yorku.ca/archives/click4hp.html . [log in to unmask] is run in collaboration with Health Nexus: http://www.healthnexus.ca/index_eng.php
|
|
|